# NVST — Envista Holdings Corp · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** NVST  
**Sources:** 18  
**Published:** 2026-10-26  
**Canonical:** https://app.k3vl4r.com/research/deep-research-nvst-envista-holdings-corp-catalysts-narrative-risks-9340

---

# Envista Holdings Corp (NYSE: NVST) — Research Brief (as of 2026-10-26)

**Company snapshot:** Envista is a global dental-products company (~$3.6–3.8B market cap) with 30+ brands (Nobel Biocare, Ormco, Kerr, DEXIS) serving dental professionals in 120–130+ countries [[8]](https://finance.yahoo.com/markets/stocks/articles/leaner-operations-improving-dental-demand-134355125.html), [[10]](https://www.stocktitan.net/news/NVST/), [[16]](https://investors.envistaco.com/), [[17]](https://finance.yahoo.com/markets/stocks/articles/envista-schedules-third-quarter-2026-201500014.html). It reports in two segments: Specialty Products & Technologies (implants, orthodontics) and Equipment & Consumables (imaging, restoratives) [[13]](https://trendmatrix.com/stocks/NVST). Its price has ranged between $18.77 and $30.42 over the past 52 weeks, and it was trading near $23.6 in late October 2026 [[2]](https://smartinvestorsdaily.com/articles/nyse-nvst-baird-downgrade-2026-10-15), [[8]](https://finance.yahoo.com/markets/stocks/articles/leaner-operations-improving-dental-demand-134355125.html), [[12]](https://stockbuyvest.com/stock/nvst).

## Key Recent Catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-nvst-envista-holdings-corp-catalysts-narrative-risks-9340 (free to sign up)._